• PDF: Delivered by email usually within 12 to 24 UK business hours.

Antigenics, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile

Antigenics, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile

Antigenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Antigenics Inc. (Antigenics) is a biotechnology company. The company is focused on the developing superior health care products and technologies for a wide range of cancers, infectious diseases and autoimmune disorders based on immunological approaches. Its business activities include research and development, regulatory and clinical affairs, manufacturing, business development, marketing, and administrative functions. The company is headquartered in New York, United States.

Global Market Direct's Antigenics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

  • Provides key company information for business intelligence needs
  • Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

  • A quick ""one-stop-shop"" to understand the company.
  • Support sales activities by understanding your customers' businesses.
  • Qualify prospective partners and suppliers.
  • Understand and respond to your competitors' business structure, strategy and prospects through.
  • Understanding the key deals which have shaped the company.
Table Of Contents Table Of Contents 2 List of Tables 2 List of Figures 2 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Antigenics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 6 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7 Antigenics, Inc., Pharmaceuticals & Healthcare, Deal Details 8 Antigenics Completes Private Placement Of 8% Senior Notes For $25 Million 8 Antigenics Completes Private Placement Of 5.25% Senior Notes For $50 Million 9 Equity Offering 10 Antigenics Completes Private Placement Of $0.8 Million 10 Antigenics Completes Private Placement Of $21 Million 11 Antigenics Completes Private Placement Of $26 Million 12 Antigenics Completes Private Placement Of $5 Million 13 Antigenics Completes Public Offering Of $56.7 Million 14 Partnerships 15 GlaxoSmithKline Extends Licensing Agreement With Antigenics 15 Key Competitors 16 Key Employees 16 Locations And Subsidiaries 16 Head Office 16 Appendix 17 Methodology 17 About Global Markets Direct 17 Contact Us 17 Disclaimer 17 List of Tables Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Antigenics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Antigenics, Inc., Deals By Sector, 2004 to YTD 2009 6 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7 Antigenics Completes Private Placement Of 8% Senior Notes For $25 Million 8 Antigenics Completes Private Placement Of 5.25% Senior Notes For $50 Million 9 Antigenics Completes Private Placement Of $0.8 Million 10 Antigenics Completes Private Placement Of $21 Million 11 Antigenics Completes Private Placement Of $26 Million 12 Antigenics Completes Private Placement Of $5 Million 13 Antigenics Completes Public Offering Of $56.7 Million 14 GlaxoSmithKline Extends Licensing Agreement With Antigenics 15 Antigenics, Inc., Key Employees 16 List of Figures Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 4 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5 Antigenics, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 6
+44 20 8816 8548

Ask a question about Antigenics, Inc. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha